Cargando…

The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations

Pituitary neuroendocrine tumors (PitNETs) are divided into multiple histological subtypes, which determine their clinical and biological variable behavior. Despite their benign evolution, in some cases, prolactin (PRL) and growth hormone (GH)-secreting PitNETs may have aggressive behavior. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumitriu-Stan, Roxana-Ioana, Burcea, Iulia-Florentina, Nastase, Valeria Nicoleta, Ceaușu, Raluca Amalia, Dumitrascu, Anda, Cocosila, Laurentiu Catalin, Bastian, Alexandra, Zurac, Sabina, Raica, Marius, Poiana, Catalina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671753/ https://www.ncbi.nlm.nih.gov/pubmed/38003353 http://dx.doi.org/10.3390/ijms242216162

Ejemplares similares

ODP293 Aberant Expression of SF-1 Transcription Factor in ACTH-secreting Pituitary Tumors: Possible Association With Aggressive Disease Evolution
por: Nastase, Valeria, et al.
Publicado: (2022)

Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation — High-Grade PitNET or PitNEC?
por: Saeger, Wolfgang, et al.
Publicado: (2021)

ODP364 Prolactinomas in men: management challenges
por: Baciu, Ionela, et al.
Publicado: (2022)

Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI
por: Amano, Taishi, et al.
Publicado: (2023)

ODP485 Hyperthyroidism with Concurrent Thyroid Cancer: Causal Relation or Incidental Association?
por: Calin, Cristiana, et al.
Publicado: (2022)

How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
por: Trouillas, Jacqueline, et al.
Publicado: (2020)

Pituitary Apoplexy in Patients with Pituitary Neuroendocrine Tumors (PitNET)
por: Gheorghe, Ana-Maria, et al.
Publicado: (2023)

PitNETs and the gut microbiota: potential connections, future directions
por: Nie, Ding, et al.
Publicado: (2023)

Prognostic Models in Growth-Hormone- and Prolactin-Secreting Pituitary Neuroendocrine Tumors: A Systematic Review
por: Dumitriu-Stan, Roxana-Ioana, et al.
Publicado: (2023)

Expression and Clinical Significance of MDM2 in Non-Functioning PitNETs
por: Yao, Xiaohui, et al.
Publicado: (2023)

Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET
por: Wang, Ruo-Qiang, et al.
Publicado: (2019)

MON-288 TSH Deficiency in Patients on Somatostatin Analog for TSH-PitNET
por: Illouz, Frederic, et al.
Publicado: (2020)

Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art
por: Feola, Tiziana, et al.
Publicado: (2022)

PMON104 Sellar Gangliocytoma-Pituitary Neuroendocrine Tumor (PitNET) Presenting As Acromegaly
por: Aurora, John, et al.
Publicado: (2022)

Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins
por: Tanabe, Noriaki, et al.
Publicado: (2023)

FRI370 Hyperthyroidism And Acromegaly In A Patient With A Mature Plurihormonal PIT1 Lineage PitNET/Adenoma
por: Slack, Daniel, et al.
Publicado: (2023)

Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
por: Serioli, Simona, et al.
Publicado: (2023)

Endoscopic Endonasal Transplanum–Transtuberculum Approach for Pituitary Adenomas/PitNET: 25 Years of Experience
por: Carretta, Alessandro, et al.
Publicado: (2023)

Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET
por: Zhang, Qilin, et al.
Publicado: (2023)

Lactotroph PitNET/adenoma associated to granulomatous hypophysitis in a patient with Crohn's disease: A case report
por: Pietrantoni, Alberto, et al.
Publicado: (2022)

SAT-267 Pregnancy in Acromegaly: Report of Five Cases
por: Burcea, Iulia Florentina, et al.
Publicado: (2020)

Endothelial progenitor cells contribute to the development of ovarian carcinoma tumor blood vessels
por: GRIGORAS, DORIN, et al.
Publicado: (2014)

P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs
por: Treppiedi, Donatella, et al.
Publicado: (2022)

Granulomatous mastitis (GM) in a young woman with a previous history of prolactin-secreting PitNET and actual normal prolactinemia
por: Boldrini, Cristiana
Publicado: (2022)

Proliferating Lymphatic Endothelial Cells as a Prognostic Marker in Head and Neck Squamous Cell Carcinoma
por: Dumitru, Cristina Stefania, et al.
Publicado: (2022)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Novel Expression of Thymine Dimers in Renal Cell Carcinoma, Demonstrated through Immunohistochemistry
por: Novacescu, Dorin, et al.
Publicado: (2022)

Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects
por: Vergeer, Rob A, et al.
Publicado: (2022)

THU099 The Challenging Management Of Silent Corticotroph PitNET—From Very Aggressive To Mild Course Of Disease During Long Follow Up
por: Bogusławska, Anna, et al.
Publicado: (2023)

Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 2. Neoplasms other than PitNET and tumor-mimicking lesions
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Human Periapical Odontogenic Granulomas: Aspects of Microvessel Density (MVD), Heterogeneity of Blood Vessels and Mast Cells Density (MCD)
por: Roi, Ciprian, et al.
Publicado: (2023)

Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 2. Neoplasms other than PitNET and tumor-mimicking lesions
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Mast cell density in the primary tumor predicts lymph node metastases in patients with breast cancer
por: Floroni, Erwin, et al.
Publicado: (2022)

The Follicular Dendritic Cells and HPV 18 Interrelation in Head and Neck Squamous Cell Carcinomas of the Larynx
por: Boia, Eugen Radu, et al.
Publicado: (2023)

The molecular profile of breast cancer: primary tumor versus corresponding lymph node metastases
por: Erwin, Floroni, et al.
Publicado: (2022)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Mast Cells: Key Players in the Shadow in Oral Inflammation and in Squamous Cell Carcinoma of the Oral Cavity
por: Gaje, Pusa Nela, et al.
Publicado: (2016)

The Prognostic-Based Approach in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors (PitNET): Tertiary Reference Center, Single Senior Surgeon, and Long-Term Follow-Up
por: Ferrés, Abel, et al.
Publicado: (2022)

The Multifaceted Role of Podoplanin Expression in Hepatocellular Carcinoma
por: Cioca, Andreea, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_14n1vjc4196qjkmtbelc58hc72